Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Диагностика и лечение инфекционного эзофагита

Литература / References

  1. Wilcox C.M. Esophagitis in the immunocompromised host. In: Castell D.O., Richter J.E., eds. The esopha- gus, 5th ed. Philadelphia: Lippincott-Raven, 2012:724–39. DOI: 10.1002/9781444346220.ch39. 5
  2. Ивашкин В.Т., Ющук Н.Д., Маев И.В., Трухманов А.С., Алексеева О.П., Лапина Т.Л., Пирогов С.С., Ткачев А.В., Шептулин А.А. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению инфекционного эзофагита. Рос журн гастроэнтерол гепатол колопроктол. 2015;25(6):77– 81. [Ivashkin V.T., Jushhuk N.D., Maev I.V., Truhma- nov A.S., Alekseyeva O.P., Lapina T.L., Pirogov S.S., Tkachev A.V., Sheptulin A.A. Diagnostics and treatment of infectious esophagitis: clinical guidelines of the Russian gastroenterological association. Rus J Gastroent Hepatol Coloproctol. 2015;25(6):77–81 (In Russ.)].
  3. O’Rourke A. Infective oesophagitis: epidemiology, cause, diagnosis and treatment options. Curr Opin Otolaryngol. Head Neck Surg. 2015;23(6):459–63. DOI: 10.1097/ МОО.0000000000000199
  4. Mulhall B.P., Wong R.K.H. Infectious Esophagitis. Curr Treat Options Gastroenterol. 2003;6(1):55–70. DOI: 10.1007/s11938-003-0034-5
  5. Forrest G. Gastrointestinal infections in immunocompro- mised hosts. Curr Opin Gastroenterol. 2004;20(1):16–21. DOI: 10.1097/00001574-200401000-00005
  6. Rosołowski M., Kierzkiewicz M. Etiology, diagnosis and treatment of infectious esophagitis. Gastroenterol. 2013;8(6):333–7. DOI: 10.5114/pg.2013.39914
  7. Ahuja N.K., Clarke J.O. Evaluation and Management of Infectious Esophagitis in Immunocompromised and Immu- nocompetent Individuals. Curr Treat Options Gastroenter- ol. 2016;14(1):28–38. DOI: 10.1007/s11938-016-0082-2
  8. Winkler B., Capo V., Reumann W., Ma A., Porta R.L., Reilly S., et al. Human papillomavirus infection of the esophagus. A clinicopathologic study with demonstration of papillomavirus antigen by the immunoperoxidase tech- nique. Cancer. 1985;55(1):149–55. DOI: 10.1002/1097- 0142(19850101)55:1
  9. Baehr P.H., McDonald G.B. Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastro- enterology. 1994;106(2):509–32. DOI: 10.1016/0016- 5085(94)90613-0.
  10. Gill R.A., Gebhard R.L., Dozeman R.L., Sumner H.W. Shingles esophagitis: endoscopic diagnosis in two patients. Gastrointest Endosc. 1984;30(1):26–7. DOI: 10.1016/ s0016-5107(84)72290-5
  11. Jain S.K., Jain S., Jain M., Yaduvanshi A. Esophageal tuberculosis: is it so rare? Report of 12 cases and review of the literature. Am. J. Gastroenterol. 2002;97(2):287–91. DOI: 10.1111/j.1572-0241.2002.05456.x
  12. Robbins and Cotran Pathologic Basis of Disease. 9th edi- tion. Philadelphia, PA: Elsevier/Saunders, 2015.
  13. López-Dupla M., Sanz P.M., Garcia V.P., Ortega E.V., Uriol P.L., Khamashta M.A., Aguado A.G. Clini- при инфекционном эзофагите — боль и затруднение при глотании. Каждому пациенту с подозрением на инфекционное поражение пищевода должно проводиться тщательное обследование на наличие инфекции и идентификации возбудителя, а также назначаться лечение, направленное на уничтожение микроорганизма (эрадикация). При неэффективности проведенного лечения следует провести повторный курс терапии с другой схемой назначения лекарственных средств. Пациенту важно соблюдать приверженность к лечению и строго контролировать прием лекарственных препаратов, а также модифицировать образ жизни, отказаться от курения и употребления алкоголя, соблюдать режим труда и отдыха. cal, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infect- ed patients: a survey of 114 cases. Am J Gastroenterol. 1992;87(12):1771–6.
  14. von Arnim U., Malfertheiner P. Eosinophilic Esophagi- tis — Treatment of Eosinophilic Esophagitis with Drugs: Corticosteroids. Dig. Dis. 2014;32(1–2):126–9. DOI: 10.1159/000357089
  15. Daniell H.W. Acid suppressing therapy as a risk factor for Candida esophagitis: Acid suppression and Candida esophagitis. Dis. Esophagus. 2016;29(5):479–83. DOI: 10.1111/dote.12354.
  16. Underwood J.A., Williams J.W., Keate R.F. Clini- cal findings and risk factors for Candida esophagitis in outpatients. Dis. Esophagus. 2003;16(2):66–9. DOI: 10.1046/j.1442-2050.2003.00305.x
  17. Jones C. Alphaherpesvirus Latency: Its Role in Disease and Survival of the Virus in Nature. Adv Virus Res. 1998;51:81–133. DOI: 10.1016/s0065-3527(08)60784-8
  18. Wagner E.K., Bloom D.C. Experimental investigation of herpes simplex virus latency. Clin. Microbiol. Rev. 1997;10(3):419–43. DOI: 10.1128/CMR.10.3.419-443.1997
  19. Jones C. Herpes Simplex Virus Type 1 and Bovine Herpes- virus 1 Latency. Clin Microbiol Rev. 2003;16(1):79–95. DOI: 10.1128/cmr.16.1.79-95.2003
  20. Itoh T., Takahashi T., Kusaka K., Kawaura K., Na- kagawa Y., Yamakawa J., Kanda T. Herpes simplex esophagitis from 1307 autopsy cases. J Gastroenterol Hepatol. 2003;18(12):1407–11. DOI: 10.1046/j.1440- 1746.2003.03166.x
  21. Mosimann F., Cuénoud P.F., Steinhäuslin F., Wauters J.P. Herpes simplex esophagitis after renal transplantation. Transpl Int. 1994;7(2):79–82. DOI: 10.1007/BF00336466
  22. McBane R.D., Gross J.B. Herpes esophagitis: clinical syndrome, endoscopic appearance, and diagnosis in 23 patients. Gastrointest Endosc. 1991;37(6):600–3. DOI: 10.1016/s0016-5107(91)70862-6
  23. Nash G., Ross J.S. Herpetic esophagitis. A common cause of esophageal ulceration. Hum Pathol. 1974;5(3):339–45. DOI: 10.1016/s0046-8177(74)80116-4
  24. DiPalma J.A., Brady C.E. Herpes simplex esophagitis in a nonimmunosuppressed host with gastroesophageal reflux. Gastrointest Endosc. 1984;30(1):24–5. DOI: 10.1016/ s0016-5107(84)72289-9
  25. Pazin G.J. Herpes simplex esophagitis after trigeminal nerve surgery. Gastroenterology. 1978;74(4):741–3.
  26. Castrillero E.C., Durán F.G., Cabello N., Martínez J.G. Herpes Esophagitis in Healthy Adults and Adolescents: Report of 3 Cases and Review of the Literature. Medi- cine (Baltimore). 2010;89(4):204–10. DOI: 10.1097/ MD.0b013e3181e949ed
  27. Marinho A.V., Bonfim V.M., Alencar L.R., Pinto S.A., Filho J.A.A. Herpetic Esophagitis in Immunocompetent Medical Student. Case Rep Infect Dis. 2014;2014:930459. DOI: 10.1155/2014/930459
  28. Ashcraft K.A., Hunzeker J., Bonneau R.H. Psychological stress impairs the local CD8+ T cell response to mucosal HSV-1 infection and allows for increased pathogenicity via a glucocorticoid receptor-mediated mechanism. Psycho- neuroendocrinology. 2008;33(7):951–63. DOI: 10.1016/j. psyneuen.2008.04.010
  29. Hoversten P., Kamboj A.K., Katzka D.A. Infections of the esophagus: an update on risk factors, diagnosis, and management. Dis Esophagus. 2018;31(12). DOI: 10.1093/ dote/doy094
  30. Wang H-W., Kuo C-J., Lin W-R., Hsu C-M., Ho Y-P., et al. The clinical characteristics and manifestations of cyto- megalovirus esophagitis. Dis Esophagus. 2016;29(4):392– 9. DOI: 10.1111/dote.12340
  31. Bonetti L.R., Losi L., Gregorio C.D., Bertani A., Merighi A., Bettelli S., et al. Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases. Scand. J. Gastroenterol. 2011;46(10):1228– 35. DOI: 10.3109/00365521.2011.594083
  32. Jain S.S., Somani P.O., Mahey R.C., Shah D.K., Con- tractor Q.Q., Rathi P.M. Esophageal tuberculosis pre- senting with hematemesis. World J Gastrointest Endosc. 2013;5(11):581. DOI: 10.4253/wjge.v5.i11.581
  33. Чернеховская Н.Е. Эндоскопическая диагностика заболеваний пищевода, желудка. М.: МЕДпресс-информ, 2010. [Chernehovskaja N.E. Endoscopic diagnostics of diseases of the esophagus, stomach. Moscow: MEDpress- inform; 2010 (ISBN 5-98322-639-8) (In Russ)].
  34. Bohn O.L., Saldivar J., Sanchez-Sosa S. Identification of human papillomavirus in esophageal squamous papillomas. World J Gastroenterol. 2008;14(46):7107. DOI: 10.3748/ wjg.14.7107
  35. Takahashi Y., Nagata N., Shimbo T., Nishijima T., Watanabe K., Aoki T., et al. Long-Term Trends in Esoph- ageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endo- scopic Study of 80,219 Patients. PLoS One. 2015;10(7). DOI: 10.1371/journal.pone.0133589
  36. Connolly G.M., Hawkins D., Harcourt-Webster J.N., Parsons P.A., Husain O.A., Gazzard B.G. Oesophageal symptoms, their causes, treatment, and prognosis in pa- tients with the acquired immunodeficiency syndrome. Gut. 1989;30(8):1033–9. DOI: 10.1136/gut.30.8.1033
  37. Bonacini M., Young T., Laine L. The causes of esopha- geal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients. Arch Intern Med. 1991;151(8):1567–72.
  38. Wilcox C.M., Alexander L.N., Clark W.S., Thomp- son S.E. Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms. Gastroenterology. 1996;110(6):1803–9. DOI: 10.1053/gast.1996.v110.pm8964406
  39. Frick T., Fryd D.S., Goodale R.L., Simmons R.L., Sutherland D.E., Najarian J.S. Incidence and treat- ment of candida esophagitis in patients undergoing renal transplantation. Data from the Minnesota prospective ran- domized trial of cyclosporine versus antilymphocyte glob- ulin-azathioprine. Am J Surg. 1988;155(2):311–3. DOI: 10.1016/s0002-9610(88)80722-0
  40. Hoversten P., Kamboj A.K., Wu T.T., Katzka D.V. Variations in the Clinical Course of Patients with Herpes Simplex Virus Esophagitis Based on Immunocompetence and Presence of Underlying Esophageal Disease. Dig. Dis. Sci. 2019;64(7):1893–900. DOI: 10.1007/s10620-019- 05493-x
  41. Шулешова А.Г., Минушкин О.Н., Данилов Д.В., Бондарева К.А. Изучение персистенции вирусной инфекции в слизистой оболочке пищевода и её возможная роль в развитии эрозивного эзофагита; лечебные подходы. Кремлевская медицина. Клинический вестник. 2017;3:105–11. [Shuleshova A.G., Minushkin O.N., Danilov D.V., Bondareva K.A. Viral persistence in esophageal mucosa and its putative role in erosive esopha- gitis development; therapeutic approaches. Kremlin Medi- cine. Clinical Bulletin. 2017; 3:105–111 (In Russ.)].

  1. Шестакова И.В., Шахгильдян В.И., Шипулина О.Ю., Прокопенко Е.И., Эсауленко Е.В., Сухорук А.А. Цитомегаловирусная болезнь у взрослых. Клинические рекомендации Международной ассоциации специалистов в области инфекций. 2016. [Shestakova I.V., Shakhgi- ldyan V.I., Shipulina O.Y., Prokopenko E.I., Esaulen- ko E.V., Sukhoruk A.A. Cytomegalovirus disease in adults. Clinical recommendations of the International Association of Specialists in Infectious Diseases. 2016. (In Russ.)] URL: https://legalacts.ru/doc/klinicheskie-rekomendatsii-tsito- megalovirusnaja-bolezn-u-vzroslykh-utv-minzdravom-rossii/
  2. Torres-Madriz G., Boucher H.W. Immunocompromised hosts: perspectives in the treatment and prophylaxis of cy- tomegalovirus disease in solid-organ transplant recipients. Clin Infect Dis. 2008;47(5):702–11. DOI: 10.1086/590934
  3. Welzel T.M., Kawan T., Bohle W., Richter G.M., Bosse A., Zoller W.G. An unusual cause of dyspha- gia: esophageal tuberculosis. J Gastrointest Liver Dis. 2010;19(3):321–4.
  4. Кузьмина А.О., Таланова О.С., Холева А.О., Савоненкова Л.Н., Арямкина О.Л. Туберкулез пищевода. Известия высших учебных заведений. Поволжский регион. Медицинские науки. 2012;4(24):82–9. [Kuzmina A.O., Talanova O.S., Kholeva A.O., Savonenkova L.N., Ary- amkina O.L. Esophageal tuberculosis. Transactions of Higher Education Institutions. Volga Region. Medical Sci- ence. 2012;4(24):82–89 (In Russ.)].
  5. Patel N., Amarapurkar D., Agal S., Baijal R., Kulshres- tha P., Pramanik S., Gupte P. Gastrointestinal luminal tuberculosis: establishing the diagnosis. J Gastroenterol Hepatol. 2004;19(11):1240–6. DOI: 10.1111/j.1440- 1746.2004.03485.x
  6. Quarto G., Sivero L., Somma P., Rosa G.D., Mosella F., Nunziata G., et al. A case of infectious esophagitis caused by human papilloma virus. Minerva Gastroenterol Dietol. 2008;54(3):317–21.
  7. Mimidis K., Papadopoulos V., Margaritis V., Thomo- poulos K., Gatopoulou A., Nikolopoulou V., Kartalis G. Predisposing factors and clinical symptoms in HIV-neg- ative patients with Candida oesophagitis: are they al- ways present? Int J Clin Pract. 2005;59(2):210–3. DOI: 10.1111/j.1742-1241.2004.00249.x
  8. Wilcox C.M., Straub R.F., Clark W.S. Prospective eval- uation of oropharyngeal findings in human immunodefi- ciency virus-infected patients with esophageal ulceration. Am J Gastroenterol. 1995;90(11):1938–41.
  9. Wilcox C.M., Straub R.F., Schwartz D.A. Cytomega- lovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome. Am J Med. 1995;98(2):169–76. DOI: 10.1016/s0002-9343(99)80400-8
  10. Orlowska J., Jarosz D., Gugulski A., Pachlewski J., Butruk E. Squamous Cell Papillomas of the Esophagus: Report of 20 Cases and Literature Review. Am. J. Gastro- enterol. 1994;89(3):434–7.
  11. Jia N., Tang Y., Li Y., Gan Y. A case report: Does the ulcer belong to esophageal carcinoma or HIV? Medi- cine (Baltimore). 2017;96(49):e9137. DOI: 10.1097/ MD.0000000000009137
  12. Ramanathan J., Rammouni M., Baran J., Khatib R. Herpes simplex virus esophagitis in the immunocompetent host: an overview. Am. J. Gastroenterol. 2000;95(9):2171– 6. DOI: 10.1111/j.1572-0241.2000.02299.x
  13. Byard R.W., Champion M.C., Orizaga M. Variability in the clinical presentation and endoscopic findings of herpetic esophagitis. Endoscopy. 1987;19(4):153–5. DOI: 10.1055/s-2007-1018267
  14. Cronstedt J.L., Bouchama A., Hainau B., Halim M., Khouqeer F., Darsouny T. Spontaneous esophageal perfo- ration in herpes simplex esophagitis. Am. J. Gastroenterol. 1992;87(1):124–7.
  15. Chalasani N., Parker K.M., Wilcox C.M. Bronchoesoph- ageal fistula as a complication of cytomegalovirus esoph- agitis in AIDS. Endoscopy. 1997;29(5):S28–29. DOI: 10.1055/s-2007-1004237

  1. Obrecht W.F., Richter J.E., Olympio G.A., Gel- fand D.W. Tracheoesophageal Fistula: A Serious Com- plication of Infectious Esophagitis. Gastroenterology. 1984;87(5):1174–79.
  2. Tomizawa M., Shinozaki F., Hasegawa R., Shirai Y., Motoyoshi Y., Sugiyama T., Yamamoto S., Ishige N. Low hemoglobin levels are associated with upper gastro- intestinal bleeding. Biomed Rep. 2016;5(3):349–52. DOI: 10.3892/br.2016.727
  3. Tomizawa M., Shinozaki F., Hasegawa R., Shirai Y., Motoyoshi Y., Sugiyama T., et al. Change ratio of he- moglobin has predictive value for upper gastrointestinal bleeding. Biomed Rep. 2016;5(4):479–82. DOI: 10.3892/ br.2016.753
  4. Clark S.F. Iron deficiency anemia. Nutr Clin Pract. 2008;23(2):128–41. DOI: 10.1177/0884533608314536
  5. Абдурахманов Д.Т. Железодефицитная анемия при заболеваниях желудочно-кишечного тракта. Фарматека. 2012;13:9–14 [Abdurakhmanov D.T. Iron deficiency anae- mia in gastrointestinal diseases. Farmateka. 2012; 13:9–14 (In Russ.)].
  6. Кучерявый Ю.А., Андреев Д.Н., Андреев Н.Г. Диагностика и лечение желудочно-кишечных кровотечений с позиций терапевта. Трудный пациент. 2014;12(6). [Kucheryaviy Yu.A., Andreev D.N., Andreev N.G. Di- agnosis and treatment of gastrointestinal bleeding, a thera- pist’s view. Difficult Patient. 2014; 12(6) (In Russ.)].
  7. Harewood G.C., McConnell J.P., Harrington J.J., Ma- honey D.W., Ahlquist D.A. Detection of occult upper gas- trointestinal tract bleeding: performance differences in fe- cal occult blood tests. Mayo Clin. Proc. 2002;77(1):23–8. DOI: 10.4065/77.1.23
  8. Jazeron J.-F., Barbe C., Frobert E., Renois F., Tal- mud D., Brixi-Benmansour H., et al. Virological diagno- sis of herpes simplex virus 1 esophagitis by quantitative re- al-time PCR assay. J Clin Microbiol. 2012;50(3):948–52. DOI: 10.1128/JCM.05748-11
  9. Muir S.W., Farquharson M.A., Wheatley D.J., McPha- den A.R. Detection of cytomegalovirus in upper gas- trointestinal biopsies from heart transplant recipients: comparison of light microscopy, immunocytochemistry, in situ hybridisation, and nested PCR. J Clin Pathol. 1998;51(11):807–11. DOI: 10.1136/jcp.51.11.807
  10. Nishimura S., Nagata N., Shimbo T., Asayama N., Aki- yama J., Ohmagari N., et al. Factors associated with esophageal candidiasis and its endoscopic severity in the era of antiretroviral therapy. PloS One. 2013;8(3):e58217. DOI: 10.1371/journal.pone.0058217
  11. Sumantri S., Simadibrata M., Mokoagow M.I., Gu- nawanjati D., Ulina S.M.M., Adhista B., et al. Can- dida Esophagitis: a Retrospective Study of Upper Gas- trointestinal Endoscopic Grading and the Characteristic Profile. Indones J Gastroenterol Hepatol Dig Endosc. 2011;12(2):95–9. DOI: 10.24871/122201195-99
  12. Jung K.H., Choi J., Gong E.J., Lee J.H., Choi K.D., Song H.J., et al. Can endoscopists differentiate cy- tomegalovirus esophagitis from herpes simplex virus esophagitis based on gross endoscopic findings? Medi- cine (Baltimore). 2019;98(23):e15845. DOI: 10.1097/ MD.0000000000015845
  13. Abid S., Jafri W., Hamid S., Khan H., Hussainy A. En- doscopic features of esophageal tuberculosis. Gastrointest Endosc. 2003;57(6):759–62. DOI: 10.1067/mge.2003.205
  14. Dahale A.S., Kumar A., Srivastava S., Varakanahal- li S., Sachdeva S., Puri A.S. Esophageal tuberculosis: Uncommon of common. JGH Open. 2018;2(2):34–8. DOI: 10.1002/jgh3.12043
  15. Fagundes R.B., Dalcin R.P., Rocha M.P., Moraes C.C., Carlotto V.S., Wink M.O. Esophageal tuberculosis. En- doscopy. 2007;39(1):е149. DOI: 10.1055/s-2007-966152
  16. Park J.H., Kim S.U., Sohn J.W., Chung I.K., Jung M.K., Jeon S.W., Kim S.K. Endoscopic find- ings and clinical features of esophageal tuberculosis. Scand J Gastroenterol. 2010;45(11):1269–72. DOI: 10.3109/00365521.2010.501524

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Литература / References
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*